- Case report
- Open Access
Cardiovascular magnetic resonance and PET-CT of left atrial paraganglioma
© Tomasian et al; licensee BioMed Central Ltd. 2010
- Received: 17 June 2009
- Accepted: 4 January 2010
- Published: 4 January 2010
Cardiac paragangliomas are among the rarest primary cardiac tumors. We present a case of left atrial paraganglioma in a patient who presented with symptoms and signs of catecholamine excess in which cardiovascular magnetic resonance in multiple orientations and PET-CT played an important role in the diagnosis and tissue characterization.
- Cardiovascular Magnetic Resonance
- Myocardial Perfusion Imaging
- Late Gadolinium Enhancement
- Steady State Free Precession
Pheochromocytomas or functioning paragangliomas are catecholamine-producing tumors arising from secretory chromograffin cells of neuroectodermal origin. These lesions commonly originate from the adrenal medulla. Approximately 18% of pheochromocytomas are extra-adrenal .Primary cardiac paragangliomas are extremely rare with less than 50 cases reported in the literature . Recent advances in cross sectional imaging have provided the potential for non-invasive and accurate diagnosis of these lesions [3–5]. In this report, we describe a left atrial paraganglioma, characterized in a multi-modality setting and confirmed on histopathology.
A 25-year-old female in her third trimester of pregnancy, presented with paroxysmal headache, palpitations, sweating, and hypertension of up to 230/130 for three weeks. Her medical history was negative for previous hypertension, and physical examination was unremarkable. Initial work-up for hypertension excluded pre-eclampsia. Further biochemistry evaluation revealed markedly elevated urine catecholamines;
The patient remained asymptomatic during the 4-month follow-up period without local recurrence on echocardiography.
Primary cardiac tumors are rare with a reported prevalence of 0.001% to 0.03% on autopsy series . Of these tumors, cardiac paragangliomas are among the rarest accounting for less than 1% of cases . These tumors originate from paraganglial cells of the arteries or the visceral autonomic paraganglia of the atria . Cardiac paragangliomas are most commonly located in the left atrium  and less frequent sites include right atrium, inter-atrial septum, and the left ventricle [1, 4, 8]. The mean age at the presentation is 36-40 years with approximately equal sex distribution . Cardiac paragangliomas are catecholeamine-secreting in 35-50% of cases .
Clinical presentations of cardiac paraganglioma range from an incidental finding  to constitutional symptoms including malaise, weight loss and fever , symptoms and signs of catecholamine excess (paroxysmal headache, palpitation, sweating, and hypertension) , arrhythmia due to invasion of the conductive system , angina pectoris or myocardial infarction secondary to compression or obstruction of coronary arteries , acute heart failure or dilated cardiomyopathy , pericardial involvement, and disruption of valvular function .
The incidence of malignancy is reported to be approximately 10% . However, there are no histological criteria to differentiate benign from malignant cardiac paragangliomas . Malignancy is determined by tumor behavior rather than histological appearance and the distinguishing feature includes presence of distant metastasis . Histopathologically, paragangliomas are monomorphous tumors composed of nests of paraganglial cells (Zellballen) surrounded by sustentacular cells .
Cardiac paragangliomas are echogenic masses on echocardiography and are reported as circumscribed, heterogeneous masses with low attenuation on un-enhanced CT  with marked enhancement on contrast enhanced CT .
These lesions can be localized using very specific radiotracers such as 131I or 123I metaiodobenzylguanidine or 18F-DOPA, which are actively transported into neurosecretory granules of catecholamine-producing cells . 18F-DOPA PET studies have yielded promising results in the imaging of pheochromocytoma , demonstrating typical intense uptake of 18F-DOPA by the paraganglional cells of the lesions, as showed in our case.
Due to its higher spatial resolution and multiplanar image acquisition, CMR is considered an important technique in diagnosis and characterization of cardiac tumors. Cine SSFP and pre-contrast T1- and T2-weighted imaging are useful for evaluation of anatomic features, whereas first pass dynamic perfusion and late gadolinium enhancement sequences are important in assessment of vascularity.
As seen in our patient, cardiac paragangliomas are typically iso- or hypo-intense relative to myocardium on T1-weighted, and markedly hyper-intense on T2-weighted images . They are highly vascular and as in our case, may typically demonstrate dynamic contrast filling on myocardial perfusion imaging which is often heterogeneous, with central non-enhancing areas suggesting tumor necrosis . Presence of peripheral rim enhancement on LGE imaging also indicates vascularity of these lesions distinguishing them from avascular cardiac masses such as thrombi and lipoma. Although presence of central dark signal on LGE could be due to nulling of signal following Inversion pulse, it likely represents tissue necrosis. Cardiac hemangiomas demonstrate LGE, intermediate and high signal intensity on T1 and T2-weighted images, respectively, and show enhancement on perfusion imaging . Cardiac lymphangiomas demonstrate high signal intensity on T1 and T2 weighted images, whereas rhabdomyomas are isointense on T1 and hyper-intense on T2 weighted images compared to adjacent myocardium .
Surgical resection of cardiac paraganglioma results in complete cure and relief of symptoms [9, 12]. Surgical risks particular to these lesions include fatal hemorrhage due to high vascularity, and hypertensive crisis from intra-operative manipulation which may be avoided by cardiopulmonary bypass allowing safe dissection. Since paragangliomas may be infiltrative lesions, as in our patient, extensive resection of the atrial wall may be required for complete excision .
The combination of CMR with various image acquisition sequences in multiple orientations and PET-CT studies, provides a powerful tool for non-invasive morphological assessment and tissue characterization of cardiac paraganglioma, especially when correlated with clinical history and appropriate biochemistry evaluations.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Manger WM: An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges. Ann N Y Acad Sci. 2006, 1073: 1-20. 10.1196/annals.1353.001.View ArticlePubMedGoogle Scholar
- Mandak JS, Benoit CH, Starkey RH, Nassef LA: Echocardiography in the evaluation of cardiac pheochromocytoma. Am Heart J. 1996, 132: 1063-6. 10.1016/S0002-8703(96)90027-7.View ArticlePubMedGoogle Scholar
- Turley AJ, Hunter S, Stewart MJ: A cardiac paraganglioma presenting with atypical chest pain. Eur J Cardiothorac Surg. 2005, 28 (2): 352-4. 10.1016/j.ejcts.2005.04.038.View ArticlePubMedGoogle Scholar
- Maxey TS, Grow P, Morris CD, Patton KT, Guyton RA: Biatrial primary cardiac paraganglioma: a rare finding. Cardiovasc Pathol. 2007, 16 (3): 179-82. 10.1016/j.carpath.2006.11.002.View ArticlePubMedGoogle Scholar
- Sawka AM, Young WF, Schaff HV: Cardiac phaeochromocytoma presenting with severe hypertension and chest pain. Clin Endocrinol. 2001, 54 (5): 689-92. 10.1046/j.1365-2265.2001.01096.x.View ArticleGoogle Scholar
- Burke A, Virmani R: Tumors of the heart and great vessels. Atlas of tumor pathology. 3rd series, fascicle 16. 1996, Washington, DC: Armed Forces Institute of PathologyGoogle Scholar
- Orringer MB, Sisson JC, Glazer G, et al: Surgical treatment of cardiac pheochromocytomas. J Thorac Cardiovasc Surg. 1985, 89: 753-757.PubMedGoogle Scholar
- Cane ME, Berrizbeitia LD, Yang SS, Mahapatro D, McGrath LB: Paraganglioma of the interatrial septum. Ann Thorac Surg. 1996, 61 (6): 1845-7. 10.1016/0003-4975(96)00066-5.View ArticlePubMedGoogle Scholar
- Jebara VA, Uva MS, Farge A, et al: Cardiac pheochromocytomas. Ann Thorac Surg. 1992, 53 (2): 356-61. Review.View ArticlePubMedGoogle Scholar
- Sardesai SH, Mourant AJ, Sivathandon Y, Farrow R, Gibbons DO: Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure. Br Heart J. 1990, 63: 234-7. 10.1136/hrt.63.4.234.PubMed CentralView ArticlePubMedGoogle Scholar
- Nomura A, Kakinoki S, Fujita M, Kitabatake A: Images in cardiovascular medicine. Malignant cardiac pheochromocytoma with bone metastases. Circulation. 1998, 97 (19): 1993-4.View ArticlePubMedGoogle Scholar
- Grebenc ML, Rosado de Christenson ML, Burke AP, et al: Primary Cardiac and Pericardial Neoplasms: Radiologic-Pathologic Correlation. Radiographics. 2000, 20: 1073-1103.View ArticlePubMedGoogle Scholar
- Hoegerle S, Nitzsche E, Altehoefer C, et al: Pheochromocytomas: detection with18F DOPA whole body PET-initial results. Radiology. 2002, 222: 507-512. 10.1148/radiol.2222010622.View ArticlePubMedGoogle Scholar
- Araoz PA, Mulvagh SL, Tazelaar HD, Julsrud PR, Breen JE: CT and MR imaging of benign primary cardiac neoplasms with echocardiographic correlation. Radiographics. 2000, 20 (5): 1303-1319.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.